Risk of Low Blood Sugar (Hypoglycemia): If you are taking GLP-1 medications for type 2 diabetes alongside other blood-sugar-lowering drugs (like insulin or sulfonylureas), drinking alcohol can be risky
CVD: cardiovascular diseases
Mounjaro is a dual-hormone agonist, meaning it mimics both GLP-1 and GIP hormones, whereas Ozempic only mimics GLP-1
However, its important to note that GLP-1RAs are not FDA-approved for type 1 diabetes, though off-label use in this context is recognized
Additionally, researchers use preclinical models to examine how the metabolic effects of dual gastric inhibitory polypeptide (GIP)/GLP-1R agonists such as tirzepatide mediate anti-inflammatory and anti-fibrotic benefits, such as in metabolic dysfunction-associated steatotic liver disease
Understanding authorized purchasing channels is essential for patient safety and medication authenticity